These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 2416646

  • 21. [Acute leukemia. Case material and therapeutic results].
    Paolino W, Resegotti L, Rossi M, Infelise V, Degani GF.
    Minerva Med; 1975 May 09; 66(35):1642-52. PubMed ID: 1055305
    [Abstract] [Full Text] [Related]

  • 22. Acute leukemia in adults: comparison of survival between a treated and an untreated group.
    Noon MA, Hess CE.
    South Med J; 1976 Sep 09; 69(9):1157-60. PubMed ID: 1067671
    [Abstract] [Full Text] [Related]

  • 23. [Treatment of acute myelogenous leukemia in adults; an account of the years 1968 to 1975].
    Willemze R, den Ottolander GJ, Heering KJ, Brand A, Zwaan FE, Haak HL, Hartgrink-Groeneveld CA, Jansen J, Eernisse JG.
    Ned Tijdschr Geneeskd; 1977 Nov 12; 121(46):1843-7. PubMed ID: 270615
    [No Abstract] [Full Text] [Related]

  • 24. Treatment of the acute leukemias.
    Bernard J, Jacquillat C, Weil M.
    Semin Hematol; 1972 Apr 12; 9(2):181-91. PubMed ID: 4553226
    [No Abstract] [Full Text] [Related]

  • 25. [Therapy of acute leukemia. Opinion of Prof. Franco Mandelli].
    Salvati A.
    Minerva Med; 1973 Jan 20; 64(4):170-2. PubMed ID: 4510268
    [No Abstract] [Full Text] [Related]

  • 26. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
    Büchner T, Hiddemann W, Berdel WE, Wörmann B, Schoch C, Fonatsch C, Löffler H, Haferlach T, Ludwig WD, Maschmeyer G, Staib P, Aul C, Gruneisen A, Lengfelder E, Frickhofen N, Kern W, Serve HL, Mesters RM, Sauerland MC, Heinecke A, German AML Cooperative Group.
    J Clin Oncol; 2003 Dec 15; 21(24):4496-504. PubMed ID: 14673036
    [Abstract] [Full Text] [Related]

  • 27. [Acute refractory lymphoblastic leukemia in the adult. Treatment with daunorubicin, cytosine arabinoside, 6-thioguanine, vincristine and prednisone].
    Marín P, Grañena A, Carreras E, Ribera JM, Rozman C.
    Sangre (Barc); 1984 Dec 15; 29(6):987-92. PubMed ID: 6598237
    [No Abstract] [Full Text] [Related]

  • 28. Acute granulocytic leukemia in adults.
    Frei E.
    N Engl J Med; 1972 Jun 01; 286(22):1211-2. PubMed ID: 4502491
    [No Abstract] [Full Text] [Related]

  • 29. Symptomatic hypophosphatemia secondary to 5-azacytidine therapy of acute nonlymphocytic leukemia.
    Ho M, Bear RA, Garvey MB.
    Cancer Treat Rep; 1976 Sep 01; 60(9):1400-2. PubMed ID: 65224
    [No Abstract] [Full Text] [Related]

  • 30. [Comparative analysis of 3 therapeutic regimens based on the combination of an anthracycline and cytosine arabinoside for remission induction in myeloblastic leukemia].
    Sanz MA, Lorenzo JI, Sanz GF, Martín Aragonés G, Rafecas FJ, Martínez JA, Gomis F.
    Sangre (Barc); 1988 Dec 01; 33(6):497-504. PubMed ID: 3247626
    [No Abstract] [Full Text] [Related]

  • 31. Remission maintenance for acute nonlymphocytic leukemia: cytosine arabinoside plus 6-thioguanine versus a sequence of drug regimens.
    Presant CA, Berger NA, Klahr C, Phillips GL.
    Cancer; 1980 Jul 01; 46(1):22-8. PubMed ID: 6930320
    [Abstract] [Full Text] [Related]

  • 32. [Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group].
    Hübner G, Link H, Schönrock-Nabulsi P, Wandt H, Gramatzki M, Löffler B, Fackler-Schwalbe I, Queisser W, Brack N, Geer T, Raab M, Ohl S, Schneider B, Schneider C, Freund M, Poliwoda H, Ehninger G.
    Med Klin (Munich); 1996 Apr 12; 91 Suppl 3():26-32. PubMed ID: 8692115
    [Abstract] [Full Text] [Related]

  • 33. [Therapy of non-lymphoid acute leukemias].
    Mandelli F.
    Minerva Med; 1975 Jul 14; 66(51):1546-52. PubMed ID: 1057048
    [No Abstract] [Full Text] [Related]

  • 34. [General remarks on the treatment of acute leukemias].
    Bernard J.
    Minerva Med; 1975 Jul 28; 66(52):2625-8. PubMed ID: 1057057
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Difficulties of remission induction treatment of acute myeloblastic leukemia].
    Fière D, Bryon PA, Martin C, Revol L.
    Sem Hop; 1974 May 26; 50(25):1691-4. PubMed ID: 4369538
    [No Abstract] [Full Text] [Related]

  • 37. A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
    Biomedicine; 1973 May 26; 18(3):192-8. PubMed ID: 4517790
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Quality of survival in patients with acute leukemia subjected to combination drug therapy].
    Almici C, Inzoli MR.
    G Clin Med; 1976 May 26; 57(5-6):183-91. PubMed ID: 1070454
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.